Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma - Tresckow, Bastian von; Fanale, Michelle; Ardeshna, Kirit M.; Chen, Robert W.; Meißner, Julia; Morschhauser, Franck; Moskowitz, Craig H.; Zinzani, Pier Luigi; Giezek, Hilde; Balakumaran, Arun; Vo, Thao T.; Rauthe, Monika Sabine; et al. (Leukemia and lymphoma, 2019)
Gesehen am 16.04.2020